• Login
0 Items
Cannin - Cannabis & Hemp Investment Group
  • Home
  • Get Free Trial
  • Cannabis & Hemp News
  • Investment Resources
    • Featured Companies
    • Company Reports
    • Stock Quotes
    • Directory
  • Contact Us
  • Login
Select Page
Ketamine One Highlights Psychedelic Research, Announces New Clinical Trial

Ketamine One Highlights Psychedelic Research, Announces New Clinical Trial

Cannabis in the News, Health, Investment Opportunities, Psychedelic Stocks, Research, Science

KGK Science Is Working With Psychedelics Companies, Pharmaceutical Enterprises and Analytical Labs to Expand Ketamine One’s Mental Health Platform Related: What are the Top 3 Psychedelic Stocks to Buy Now? Ketamine One Highlights Psychedelic Research, Announces New...
Global CBD Oil Market Expected to Hit $27.9 million by 2027

Global CBD Oil Market Expected to Hit $27.9 million by 2027

Cannabis in the News, CBD in the News, CBD Stocks, Hemp, International Cannabis News, Investment Opportunities, Research

Today, Proficient Market released an exclusive research report outlining the growth of the global CBD Oil market and how it is expected to hit $27.9 million by 2027. This report provides a detailed analysis of the CBD oil market by type (THC dominant, CBD dominant,...
Is Microdosing Psychedelics Good for You?

Is Microdosing Psychedelics Good for You?

Cannabis in the News, Psychedelic Stocks, Research, Safety, Science

If you have been following the trends lately, you might have noticed a considered increase in the number of people microdosing on psychedelics regularly. Several stories have come out about how Silicon Valley entrepreneurs microdose on psychedelics regularly and how...
HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York

HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York

Cannabis in the News, CBD in the News, CBD Stocks, Hemp, HempFusion, Investment Opportunities, Research, Science

HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York DENVER, Colo., Feb 17, 2021 – HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD...
Why are Psychedelics Vital to the Future of the Mental Health Industry?

Why are Psychedelics Vital to the Future of the Mental Health Industry?

Cannabis in the News, Health, Research, Science

Why are Psychedelics Vital to the Future of the Mental Health Industry? The Covid19 pandemic has certainly been detrimental to the mental well-being of many people in the world this year.  Lockdowns, curfews, working from home, not being allowed to see each other as...
Zelira Therapeutics Completes World’s First Clinical Trials for Treatment of Insomnia with Medical Cannabis

Zelira Therapeutics Completes World’s First Clinical Trials for Treatment of Insomnia with Medical Cannabis

Cannabis in the News, Research

Zelira Therapeutics Completes World’s First Clinical Trials for Treatment of Insomnia with Medical Cannabis Industry’s first clinically validated cannabinoid-based insomnia medication will launch globally PHILADELPHIA, April 7, 2020 /PRNewswire/...
« Older Entries

Search Cannabis and Hemp Stocks

Best Hemp Stocks 2021 - Cannin Report

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Recent Posts

  • Ketamine One Highlights Psychedelic Research, Announces New Clinical Trial
  • Medical Marijuana, Inc. Names New CEO
  • PAOG CBD Nutraceuticals Rollout On Track Targeting $5 Billon Market
  • Organic Soft Drinks Market Trends Include CBD-Infusion, Zero Calorie, And Other Product Innovations
  • Cresco Labs Launches Social Justice Campaign on 50th Anniversary of War on Drugs
  • Four Cannabis Stocks for the Summer of 2021
  • Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
https://youtu.be/5TI-sFD94Js
HempFusion TSX CBD Hemp Stocks

Cannabis Stock Watchlist

×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
Symbol Last Price % Change

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

CanninPlus Best Cannabis Stocks 2021

Cannin Monthly Subscription with Trading Alerts

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$99 / month after 30-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374

Cannin’s Track Record

Best Hemp Stocks 2021

The Best Cannabis Stocks for 2021

  • Cannin Report Q1 2021 Cannin Report Q2 2021 $99.00 $49.00
  • Cannin Report Q1 2021 Cannin Report Q1 2021 - Planet 13 Holdings $19.00 $4.99
  • Cannin Report Q1 2021 Cannin Report Q1 2021 - Innovative Industrial Properties $19.00 $4.99
  • Cannin Report Q1 2021 Cannin Report Q1 2021 $99.00 $49.00
  • The Cannin Report 2020 $49.00 $19.00

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

HempFusion TSX CBD Hemp Stocks

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205
Terms:
First Month $1, then $39/month. Cancel Anytime.
First Name Required
Last Name Required
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above
Terms:
First Month $1 then $99/month. Cancel Anytime.
First Name Required
Last Name Required
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above